Important differences in the frequency and types of mutations have been noted across the two regions—for example, although KIAA1549-BRAF fusions are detected in astrocytomas in both regions, their frequency and breakpoint locations have been noted to differ (85, 86). This evidence concerns the gene KIAA1549 and astrocytoma (excluding glioblastoma).